Phase 1B/2 study of the HSP90 inhibitor AUY922 plus trastuzumab in metastatic HER2-positive breast cancer patients who have progressed on trastuzumab-based regimen

Anthony Kong, Daniel Rea, Samreen Ahmed, J Thaddeus Beck, Rafael López López, Laura Biganzoli, Anne C Armstrong, Massimo Aglietta, Emilio Alba, Mario Campone, Shu-Fang Hsu Schmitz, Caroline Lefebvre, Mikhail Akimov, Soo-Chin Lee

Research output: Contribution to journal › Article › peer-review

23 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Phase 1B/2 study of the HSP90 inhibitor AUY922 plus trastuzumab in metastatic HER2-positive breast cancer patients who have progressed on trastuzumab-based regimen'. Together they form a unique fingerprint.

Medicine & Life Sciences